Journal Responds to Controversy Over Embryo Gene-Editing Paper
By Jocelyn Kaiser,
Science Magazine
| 04. 28. 2015
Untitled Document
The journal that days ago published the first-ever paper on an attempt to genetically modify human embryos has come out in defense of its decision and rebuffed claims that the paper was not adequately peer reviewed.
The paper appeared online on 18 April in Protein & Cell, which is co-published by Springer and an affiliate of China’s Ministry of Education. Junjiu Huang and colleagues at Sun Yat-sen University in Guangzhou describe their efforts to use the CRISPR-Cas9 gene-editing technology to alter a gene in abnormal human embryos. Their gene-editing effort was not very successful and introduced many unintentional mutations.
The paper has touched off a furor from scientists and others who have called for a moratorium on any efforts to establish a pregnancy with such a genetically modified embryo. Many have deemed Huang’s experiment unethical, and Huang himself has reportedly said that the paper was rejected by Science and Nature in part for ethical reasons.
This week, Protein & Cell defended its decision to publish the paper. An editorial posted online on 28 April says the journal’s...
Related Articles
By Carl Zimmer, The New York Times | 06.04.2026
Scientists at Columbia University have edited the DNA of early human embryos with unprecedented accuracy, an achievement that could open the way to babies engineered with particular characteristics.
The prospect has fueled controversy for years. On the one hand, the...
Faster, Higher, Stronger was the Olympic motto from 1874 until 2001, when “ – Together” was added, to stress the “moral and educational perspective” of the Games. The folks who paid for or participated in the Enhanced Games – the name itself a nod to the Olympics – held in Las Vegas on Sunday, May 24, apparently use a different edit:
Faster, Higher, Stronger with Chemistry
High-level sport draws huge crowds. Coming very soon, the soccer World Cup, featuring...
By Gina Kolata, The New York Times | 05.25.2026
In a small, preliminary study, an experimental gene-editing treatment dramatically lowered cholesterol levels, perhaps permanently, after just one infusion, scientists reported on Monday.
If confirmed in larger studies, researchers hope the findings may lead to a one-and-done way to prevent...
By Ryan Cross, Endpoint News | 05.20.2026
BOSTON — Over the past year, I’ve begun hearing rumblings from scientists who secretly think it’s time to stop being stodgy about editing the genes of human embryos.
For the most part, they are still too timid to speak up...
